Quick Takeaways
- Carol Schafer has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,366,340.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Carol Schafer
- Location
- New York, NY
- Summary
- The estimated net worth of Carol Schafer is at least $4,366,340 dollars as of 28 Jan 2026. Carol Schafer is the Director of INSMED Inc and owns shares of INSMED Inc (INSM) stock worth about $4.37M.
- Signature
- /s/ Steve Forte, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Carol Schafer and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: INSMED Inc ($4,366,340).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Carol Schafer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INSM | INSMED Inc | Director | $4,366,340 | 15 May 2025 | ||
| RPTX | Repare Therapeutics Inc. | Director | $0 | 28 Jan 2026 | ||
| IDRA | IDERA PHARMACEUTICALS, INC. | Director | 23 Jun 2022 | |||
| IMNM | Immunome Inc. | Director | 10 Jun 2025 | |||
| KURA | Kura Oncology, Inc. | Director | 05 Jun 2025 |
Insider Transactions Reported by Carol Schafer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.